当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Tang Wai Kwong
The field of neuroscience has made significant advancements in the treatment of brain developmental disorders. These innovations include new diagnostic tools, such as brain imaging and genetic testing, that allow clinicians to more accurately diagnose and treat neurological conditions. Advances in pharmacology have led to the development of new medications that target specific neurotransmitters and brain circuits, improving treatment options for conditions such as autism and Attention Deficit Hyperactivity Disorder (ADHD). In addition, researchers are exploring the potential of non-invasive brain stimulation techniques, such as Transcranial Magnetic Stimulation (TMS) and transcranial Direct Current Stimulation (tDCS), as alternative treatment options for developmental disorders. Overall, the innovations in neuroscience are transforming our understanding and treatment of brain developmental disorders, offering new hope for individuals and families affected by these conditions.